marco gobbi
marco gobbi
professore di ematologia universitą di genova
Verified email at unige.it
TitleCited byYear
Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.
F Caligaris-Cappio, M Gobbi, M Bofill, G Janossy
Journal of Experimental Medicine 155 (2), 623-628, 1982
5371982
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or-intolerant accelerated-phase chronic …
P Le Coutre, OG Ottmann, F Giles, DW Kim, J Cortes, N Gattermann, ...
Blood 111 (4), 1834-1839, 2008
3422008
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study
F Frassoni, F Gualandi, M Podestą, AM Raiola, A Ibatici, G Piaggio, ...
The lancet oncology 9 (9), 831-839, 2008
2472008
Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts
AM Raiola, A Dominietto, C di Grazia, T Lamparelli, F Gualandi, A Ibatici, ...
Biology of Blood and Marrow Transplantation 20 (10), 1573-1579, 2014
1932014
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma
PL Zinzani, A Pulsoni, A Perrotti, S Soverini, F Zaja, A De Renzo, S Storti, ...
Journal of clinical oncology 22 (13), 2654-2661, 2004
1812004
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma
PL Zinzani, E Pavone, S Storti, L Moretti, PP Fattori, L Guardigni, B Falini, ...
Blood 89 (11), 3974-3979, 1997
1791997
Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors
A Poggi, C Prevosto, AM Massaro, S Negrini, S Urbani, I Pierri, ...
The Journal of Immunology 175 (10), 6352-6360, 2005
1722005
Elderly aggressive-histology non-Hodgkin’s lymphoma: first-line VNCOP-B regimen experience on 350 patients
PL Zinzani, S Storti, A Zaccaria, L Moretti, M Magagnoli, E Pavone, ...
Blood 94 (1), 33-38, 1999
1721999
Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid
A Poggi, C Venturino, S Catellani, M Clavio, M Miglino, M Gobbi, A Steinle, ...
Cancer research 64 (24), 9172-9179, 2004
1602004
Normal equivalent cells of B cell malignancies: analysis with monoclonal antibodies
M Gobbi, F Caligaris‐Cappio, G Janossy
British journal of haematology 54 (3), 393-403, 1983
1421983
FLAG (fludarabine+ high-dose cytarabine+ G-CSF): an effective and tolerable protocol for the treatment of'poor risk'acute myeloid leukemias.
G Visani, P Tosi, PL Zinzani, S Manfroi, E Ottaviani, N Testoni, M Clavio, ...
Leukemia 8 (11), 1842-1846, 1994
1401994
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
P Tosi, E Zamagni, C Cellini, S Ronconi, F Patriarca, F Ballerini, P Musto, ...
Journal of the Peripheral Nervous System 7 (3), 209-209, 2002
1342002
Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas
J Gerdes, H Stein, S Pileri, MT Rivano, M Gobbi, E Ralfkiaer, KM Nielsen, ...
The Lancet 330 (8556), 448-449, 1987
1341987
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma
PL Zinzani, M Magagnoli, L Moretti, A De Renzo, R Battista, A Zaccaria, ...
Journal of Clinical Oncology 18 (4), 773-773, 2000
1242000
Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma?
A Monteverde, MT Rivano, GC Allegra, AI Monteverde, P Zigrossi, ...
Acta haematologica 79 (1), 20-25, 1988
1231988
Immunohistochemical detection of the multidrug transport protein P1 70 in human normal tissues and malignant lymphomas
SA Pileri, E Sabattini, B Falini, PL Tazzari, F Gherlinzoni, MG Michieli, ...
Histopathology 19 (2), 131-140, 1991
1141991
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells
D De Totero, R Meazza, S Zupo, G Cutrona, S Matis, M Colombo, ...
Blood 107 (9), 3708-3715, 2006
1132006
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways
D De Totero, R Meazza, M Capaia, M Fabbi, B Azzarone, E Balleari, ...
Blood 111 (2), 517-524, 2008
1072008
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes
MT Voso, V Santini, C Finelli, P Musto, E Pogliani, E Angelucci, G Fioritoni, ...
Clinical cancer research 15 (15), 5002-5007, 2009
1042009
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia
M Clavio, P Carrara, M Miglino, I Pierri, L Canepa, E Balleari, AM Gatti, ...
Haematologica 81 (6), 513-520, 1996
1021996
The system can't perform the operation now. Try again later.
Articles 1–20